Smart-Phone Safety Behavior Fading Intervention for Appearance Concerns (Open ARSB Study)
NCT ID: NCT06896435
Last Updated: 2025-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
401 participants
INTERVENTIONAL
2025-04-15
2025-09-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Text Message Safety Behavior Fading for Social Anxiety
NCT06168253
Expressive Interviewing Agents to Support Health-Related Behavior Change
NCT05949840
A Smartphone Intervention for Relational and Mental Well Being
NCT04629755
Promoting Well-being and Health in Heart Failure
NCT04829617
Mobile Mental Health Stigma Reduction Intervention Among Black Adults
NCT06316804
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Safety Behavior Fading
Individuals randomly assigned to the safety behavior fading condition will receive instructions to decrease or eliminate their endorsed appearance-related safety behaviors. In addition, they will receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they engaged in each safety behavior over the previous day.
Safety Behavior Fading for Appearance Concerns
Participants are asked to reduce or eliminate safety behaviors via text message reminders and checklists to monitor progress.
Relaxing Video
Individuals randomly assigned to the relaxing video condition will receive a total of 4 videos over the course of a month (1 video per week, 15 minutes each) wherein participants will be invited to close their eyes and focus their attention on the present moment while listening to relaxing piano music and songbirds.
Relaxing Video
Participants are asked to view weekly videos lasting 15 minutes each to engage in relaxation exercises.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Safety Behavior Fading for Appearance Concerns
Participants are asked to reduce or eliminate safety behaviors via text message reminders and checklists to monitor progress.
Relaxing Video
Participants are asked to view weekly videos lasting 15 minutes each to engage in relaxation exercises.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* If applicable, unstable psychiatric medication usage any time over the past 4 weeks
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Florida State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jesse Cougle
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jesse Cougle, Doctor of Philosophy
Role: STUDY_DIRECTOR
Florida State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Florida State University
Tallahassee, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00005977
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.